High throughput proteome screening for biomarker detection.
about
Applications of diagonal chromatography for proteome-wide characterization of protein modifications and activity-based analyses.A uniform proteomics MS/MS analysis platform utilizing open XML file formatsQuantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Deconvolution filters to enhance resolution of dense time-of-flight survey spectra in the time-lag optimization range.Human body fluid proteome analysis.Absolute multiplexed quantitative analysis of protein expression during muscle development using QconCAT.Direct tissue proteomics in human diseases: potential applications to melanoma research.Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11BioSunMS: a plug-in-based software for the management of patients information and the analysis of peptide profiles from mass spectrometry.Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry.MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.Glycoproteomics in neurodegenerative diseases.A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS.A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics dataA rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC/MS and its application for accurate and sensitive quantification of carbonyl reductases in human liver.The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.High throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platformBiomarker discovery in neurodegenerative diseases: a proteomic approach.Identification of glycoproteins from mouse skin tumors and plasmaMass spectrometry based glycoproteomics--from a proteomics perspectiveUsing an isolated rat kidney model to identify kidney origin proteins in urine.Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseUniPep--a database for human N-linked glycosites: a resource for biomarker discovery.Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkersIdentification of glycoproteins containing specific glycans using a lectin-chemical method.Proteomic profiling of pancreatic cancer for biomarker discovery.Mass spectrometry-based expression profiling of clinical prostate cancer.Insulin growth factor 1 like receptor (IGF-1R).Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in SerumThematic review series: systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases.Proteomic applications of protein quantification by isotope-dilution mass spectrometry.Proteomics studies of pancreatic cancerDevelopment of a high-throughput IMS-IMS-MS approach for analyzing mixtures of biomoleculesMass spectrometry based targeted protein quantification: methods and applications.Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?Electrostatic control of peptide side-chain reactivity using amphiphilic homopolymer-based supramolecular assemblies.Mass spectrometry-based approaches toward absolute quantitative proteomics.ICP-MS-based strategies for protein quantification.Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
P2860
Q30365942-B5417E1E-3F7E-414F-A760-69245A4465AFQ30478423-A8D3772C-2D9B-459E-B5A9-3A881562D2A8Q30576595-1F5CE45E-62E5-4409-B9B0-53D9265EC841Q30813704-6418A2C5-21DC-4178-9F7C-8C67D08BFA92Q33262623-2C002D94-D71E-4BDF-8AF2-F999EEA46868Q33284987-C524AB24-ACC9-4046-99BA-E93C884BE3A1Q33340658-2711EB74-A85C-40BA-8E24-7D098BF889A6Q33388693-5D105363-ACEA-44B9-9C61-426C8BC2FD2BQ33409779-66498353-97E9-4736-B6F9-B2AE18C3AFFEQ33516156-D68FB700-C4A4-4105-908C-741C857E319AQ33523561-ABF86B93-F4DE-4F46-87AE-81250E822B23Q33563387-29098A65-2EE4-4826-A416-8D71B7C21C39Q33778879-C5ABB8B7-4C17-4412-A331-F3A0D7C8C522Q33791102-351077E7-B0B1-44AA-B4B3-0A9B85C5834CQ33906808-3269120A-07CB-4DAA-BAC1-5D629100406AQ34073701-E826C973-C1F2-4DD9-B7DE-FE61C66F8279Q34074494-7D322657-8C05-4BCE-91B0-97B600581876Q34125681-11B25CCE-F878-458D-A730-75D2D20C5259Q34289533-10A37240-981A-4CC9-9BC1-3D4D41B93D9CQ34454989-8FE06D1A-3E43-455D-91D0-6411DCF187F6Q34794421-F0157E94-C3AB-4FFE-81D7-7798E109709DQ35125001-9FFA6E97-2386-498F-9279-B98FE3BD460AQ35606070-2712CB79-51C4-49C0-B82B-2040A0E7B4F5Q35751680-2315DA0D-C3DE-4131-BCBD-1C3F64A1312EQ35833266-2A282394-1C13-470C-A06F-0FCD17202B9DQ36026306-16131481-5EE1-4EC1-8AD8-A05518E2BE1FQ36032608-6402B041-EBCC-4C42-98FF-A0EC563D1C95Q36157136-965C09A4-4014-4B77-8943-2AF726060339Q36408948-9AED1CEC-ED3D-462E-92C9-6DC0D04932A9Q36451478-A1D9E68D-82E1-429D-AE72-23CDA8C522DEQ36634821-C14C1AF4-4CC3-4872-BAB6-11ACD233D423Q36689092-0EAD720D-F125-4158-99A3-590A019A2BCCQ36772529-0A4D02BC-6856-4128-A7A1-D82AA7170506Q37060634-96728EAC-11D6-4BEB-99CB-8FFC557B42B0Q37134146-B4E35BB4-3E68-425B-9681-773D81565DD5Q37193620-D8C92FEB-46BB-4388-A9DA-FDA6D67AE672Q37332772-B3915081-06B6-4FFC-8DF4-B0963DC8389BQ37487626-711DFFE9-1054-4307-B43F-0F3C0DF2A70EQ37506282-836BDD5F-B7ED-48C1-BFF1-E5038B7CAD05Q37593989-0A2119B8-9622-4872-9604-34182C896D28
P2860
High throughput proteome screening for biomarker detection.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
High throughput proteome screening for biomarker detection.
@ast
High throughput proteome screening for biomarker detection.
@en
type
label
High throughput proteome screening for biomarker detection.
@ast
High throughput proteome screening for biomarker detection.
@en
prefLabel
High throughput proteome screening for biomarker detection.
@ast
High throughput proteome screening for biomarker detection.
@en
P2093
P2860
P1476
High throughput proteome screening for biomarker detection.
@en
P2093
Dale Patterson
Michael J Comb
Ning Zhang
P2860
P304
P356
10.1074/MCP.M400161-MCP200
P577
2005-01-05T00:00:00Z